The presidency of Donald Trump represented a relatively unique event in modern American history, whereby a sitting US president made numerous controversial remarks about minoritized groups yet nonetheless maintained substantial public support. Trump's comments constituted a departure from the egalitarian norms that had long characterized American political discourse. Here, we examine the potential effects of Trump's rhetoric on Americans' attitudes, predicting that these high-profile norm violations may have reshaped the personal prejudices of the American people. In 13 studies including over 10,000 participants, we tested how Americans' prejudice changed following the political ascension of Donald Trump. We found that explicit racial and religious prejudice significantly increased amongst Trump's supporters, whereas individuals opposed to Trump exhibited decreases in prejudice. Further, changing social norms appear to explain these changes in prejudice. These results suggest that Trump's presidency coincided with a substantial change in the topography of prejudice in the United States.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41562-021-01287-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Oncologists use molecular prediction/pharmacogenomics to improve Rx of cancer. Voltaire now wrong.
View Article and Find Full Text PDFPatient attendance at molecular tumor board: A new means of shared decision making?
Curr Probl Cancer
June 2022
Department of Oncology, Associate Professor University of Virginia, Inova Schar Cancer Institute, Fairfax, VA.
Patient engagement in medical decision-making improves patient related outcomes through compliance and patient satisfaction. The Inova Schar Cancer Institute has a weekly molecular tumor board (MTB) to match comprehensive genomic sequencing results with targeted therapies for patients. Primary oncologists extended MTB invitations to their patients.
View Article and Find Full Text PDFObjectives: To analyze the impact of neoadjuvant chemotherapy on survival and recurrence patterns in muscle-invasive bladder cancer after robot-assisted radical cystectomy.
Materials And Methods: The International Robotic Cystectomy Consortium database was reviewed to identify patients who underwent robot-assisted radical cystectomy for muscle-invasive bladder cancer between 2002 and 2019. Survival outcomes, response rates, and recurrence patterns were compared between patients who received neoadjuvant chemotherapy and those who did not.
A Rare Variant in (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree.
Cancers (Basel)
May 2021
Inova Schar Cancer Institute, Inova Health System, 8081 Innovation Park Drive, Fairfax, VA 22031, USA.
Pairs of related bladder cancer cases who belong to pedigrees with an excess of bladder cancer were sequenced to identify rare, shared variants as candidate predisposition variants. Candidate variants were tested for association with bladder cancer risk. A validated variant was assayed for segregation to other related cancer cases, and the predicted protein structure of this variant was analyzed.
View Article and Find Full Text PDFCharacterization of Brain Metastases in Urothelial Cancers.
Clin Genitourin Cancer
December 2020
Genitourinary Oncology, Inova Schar Cancer Institute, Fairfax, VA. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!